Regulation & law · 25/09/1995

U.S. Patent Application for Dengue Vaccine Now Available for Licensing

The U.S. Patent Office has made available for licensing a patent application for a recombinant vaccine against the dengue virus, filed on May 2, 1995, with Serial No. 08/433,263, which is owned by the U.S. Government and administered by the Secretary of the Army.